What is the management approach for Posterior Reversible Encephalopathy Syndrome (PRES syndrome)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The management of Posterior Reversible Encephalopathy Syndrome (PRES) should focus on immediate discontinuation of offending medications, correction of electrolytes, and symptomatic treatment with benzodiazepines, as well as stringent control of blood pressure, particularly in hypertensive patients. The treatment approach for PRES is primarily symptomatic and aims to address the underlying cause of the condition 1. Key aspects of management include:

  • Discontinuation of medications known to induce PRES, such as ifosfamide 1
  • Correction of electrolyte imbalances, if present 1
  • Symptomatic treatment with benzodiazepines for seizure management 1
  • Stringent control of blood pressure to prevent further cerebral injury 1
  • Supportive care, including airway protection, maintaining adequate oxygenation, and preventing complications in unconscious patients

In terms of blood pressure management, it is crucial to lower blood pressure gradually to avoid cerebral hypoperfusion 1. The use of intravenous antihypertensive medications, such as labetalol or nicardipine, may be necessary to achieve this goal. Seizure management with antiepileptic drugs, such as levetiracetam, may also be indicated in patients experiencing seizures 1. However, long-term antiepileptic therapy is typically unnecessary, as seizures are usually self-limited. Overall, prompt recognition and treatment of PRES are essential to prevent permanent neurological damage and improve patient outcomes 1.

From the Research

Management Approach for Posterior Reversible Encephalopathy Syndrome (PRES)

The management approach for Posterior Reversible Encephalopathy Syndrome (PRES) involves several key components, including:

  • Normalization of blood pressure to prevent further neurological damage 2
  • Treatment of seizures, which can be a symptom of PRES, using antiepileptic drugs 2, 3
  • Withdrawal or adjustment of immunosuppressive therapy, which can be a precipitant of PRES 4, 3
  • Management of underlying medical conditions, such as hypertensive encephalopathy or eclampsia 2, 5

Treatment of Seizures in PRES

Seizures are a common symptom of PRES, and their treatment is crucial to prevent further neurological damage. The use of antiepileptic drugs, such as phenytoin or levetiracetam, has been recommended for seizure prophylaxis in patients with traumatic brain injury 6. Similarly, in patients with PRES, antiepileptic drugs can be used to control seizures and prevent their recurrence.

Importance of Early Diagnosis and Treatment

Early diagnosis and treatment of PRES are essential to prevent chronic neurological sequelae. Delayed diagnosis and therapy can result in irreversible neurological damage, such as chronic epilepsy 2. Therefore, it is crucial to recognize the symptoms of PRES, including headache, altered mental status, and seizures, and to initiate treatment promptly.

Role of Imaging Studies in Diagnosis

Imaging studies, such as magnetic resonance imaging (MRI), play a crucial role in the diagnosis of PRES. MRI can show characteristic changes in the brain, including white matter edema and cortical-subcortical malacia in the parietal-occipital regions 2, 4. These changes can help confirm the diagnosis of PRES and guide treatment.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical spectrum and critical care management of Posterior Reversible Encephalopathy Syndrome (PRES).

Medical science monitor : international medical journal of experimental and clinical research, 2005

Research

Posterior reversible encephalopathy syndrome following pembrolizumab therapy for relapsed Hodgkin's lymphoma.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2017

Research

Use of antiepileptics for seizure prophylaxis after traumatic brain injury.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.